{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:33:42Z","timestamp":1774251222835,"version":"3.50.1"},"reference-count":49,"publisher":"Pleiades Publishing Ltd","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Her. Russ. Acad. Sci."],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1134\/s1019331622040086","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T16:05:31Z","timestamp":1662480331000},"page":"418-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intensive Care of Patients with COVID-19"],"prefix":"10.1134","volume":"92","author":[{"given":"S. S.","family":"Petrikov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. A.","family":"Popugaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. V.","family":"Zhuravel\u2019","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"7378_CR1","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G. Chen","year":"2020","unstructured":"G. Chen, D. Wu, W. Guo, et al., \u201cClinical and immunological features of severe and moderate coronavirus disease 2019,\u201d J. Clin. Invest. 130 (5), 2620\u20132629 (2020).","journal-title":"J. Clin. Invest."},{"key":"7378_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature01326","volume":"420","author":"J. Cohen","year":"2002","unstructured":"J. Cohen, \u201cThe immunopathogenesis of sepsis,\u201d Nature 420 (6917), 885\u2013891 (2002).","journal-title":"Nature"},{"key":"7378_CR3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/jmv.25770","volume":"92","author":"Y. Gao","year":"2020","unstructured":"Y. Gao, T. Li, M. Han, et al., \u201cDiagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19,\u201d J. Med. Virol. 92 (7), 791\u2013796 (2020).","journal-title":"J. Med. Virol."},{"key":"7378_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2217\/imt-2016-0020","volume":"8","author":"T. Tanaka","year":"2016","unstructured":"T. Tanaka, M. Narazaki, T. Kishimoto, \u201cImmunotherapeutic implications of IL-6 blockade for cytokine storm,\u201d Immunotherapy 8 (8), 959\u2013970 (2016).","journal-title":"Immunotherapy"},{"key":"7378_CR5","unstructured":"Interim Guidelines: Prevention, Diagnosis, and Treatment of Novel Coronavirus Infection (COVID-19), Version 14 (Dec. 27, 2021) (Ministry of Health of the Russian Federation, 2021). https:\/\/static-0.minzdrav.gov.ru\/system\/attachments\/attaches\/000\/059\/041\/original\/BMP_COVID-19_V14_27-12-2021.pdf"},{"key":"7378_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/bjd.18898","volume":"183","author":"E. L. Simpson","year":"2020","unstructured":"E. L. Simpson, J. P. Lacour, L. Spelman, et al., \u201cBaricitinib in patients with moderate-severe atopic dermatitis and inadequate response to topical corticosteroids: Results from two randomized monotherapy phase III trials,\u201d Br. J. Dermatol. 183 (2), 242\u2013255 (2020).","journal-title":"Br. J. Dermatol."},{"key":"7378_CR7","doi-asserted-by":"crossref","unstructured":"P. Keith, M. Day, L. Perkins, et al., \u201cA novel treatment approach to the novel coronavirus: An argument for the use of therapeutic plasma exchange for fulminant COVID-19,\u201d Crit. Care 24 (1), Article no. 128 (2020).","DOI":"10.1186\/s13054-020-2836-4"},{"key":"7378_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/AIA.0000000000000220","volume":"57","author":"M. Ramanan","year":"2019","unstructured":"M. Ramanan, J. Cohen, and B. Venkatesh, \u201cSteroids and sepsis: The debate continues,\u201d Int. Anesthesiol. Clin. 57 (2), 17\u201330 (2019).","journal-title":"Int. Anesthesiol. Clin."},{"key":"7378_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(67)90168-7","volume":"2","author":"D. G. Ashbaugh","year":"1967","unstructured":"D. G. Ashbaugh, D. B. Bigelow, T. L. Petty, and B. E. Levine, \u201cAcute respiratory distress in adults,\u201d Lancet 2 (7511), 319\u2013323 (1967).","journal-title":"Lancet"},{"key":"7378_CR10","doi-asserted-by":"publisher","first-page":"E756","DOI":"10.1503\/cmaj.200645","volume":"192","author":"Z. Ye","year":"2020","unstructured":"Z. Ye, Y. Wang, L. E. Colunga-Lozano, et al., \u201cEfficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia, and acute respiratory distress syndrome: A systematic review and meta-analysis,\u201d CMAJ 192 (27), E756\u2013E767 (2020).","journal-title":"CMAJ"},{"key":"7378_CR11","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"J. A. C. Sterne","year":"2020","unstructured":"J. A. C. Sterne et al., REACT Collab., \u201cAssociation between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis,\u201d JAMA 324 (13), 1330\u20131341 (2020).","journal-title":"JAMA"},{"key":"7378_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L. Mao","year":"2020","unstructured":"L. Mao, H. Jin, M. Wang, et al., \u201cNeurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China,\u201d JAMA Neurol. 77 (6), 683\u2013690 (2020).","journal-title":"JAMA Neurol."},{"key":"7378_CR13","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/jth.14830","volume":"18","author":"S. Cui","year":"2020","unstructured":"S. Cui, S. Chen, X. Li, et al., \u201cPrevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia,\u201d J. Thromb. Haemost. 18 (6), 1421\u20131424 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"7378_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"F. A. Klok","year":"2020","unstructured":"F. A. Klok, M. Kruip, N. J. M. van der Meer, et al., \u201cIncidence of thrombotic complications in critically ill ICU patients with COVID-19,\u201d Thromb. Res. 191, 145\u2013147 (2020).","journal-title":"Thromb. Res."},{"key":"7378_CR15","doi-asserted-by":"crossref","unstructured":"A. Flaczyk, R. P. Rosovsky, C. T. Reed, et al., \u201cComparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: Implications for clinical practice and future investigations,\u201d Crit. Care 24 (1), Article no. 559 (2020).","DOI":"10.1186\/s13054-020-03273-y"},{"key":"7378_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s11239-020-02242-0","volume":"51","author":"V. Carfora","year":"2021","unstructured":"V. Carfora, G. Spiniello, R. Ricciolino, et al., \u201cAnticoagulant treatment in COVID-19: A narrative review,\u201d J.\u00a0Thromb. Thrombolysis. 51 (3), 642\u2013648 (2021).","journal-title":"J.\u00a0Thromb. Thrombolysis."},{"key":"7378_CR17","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1055\/s-0040-1712097","volume":"120","author":"M. Cattaneo","year":"2020","unstructured":"M. Cattaneo, E. M. Bertinato, S. Birocchi, et al., \u201cPulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified?,\u201d Thromb. Haemost. 120 (8), 1230\u20131232 (2020).","journal-title":"Thromb. Haemost."},{"key":"7378_CR18","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1056\/NEJM200209263471316","volume":"347","author":"B. L. Davidson","year":"2002","unstructured":"B. L. Davidson, W. H. Geerts, and A. W. Lensing, \u201cLow-dose heparin for severe sepsis,\u201d New Engl J. Med. 347 (13), 1036\u20131037 (2002).","journal-title":"New Engl J. Med."},{"key":"7378_CR19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.amjcard.2008.05.025","volume":"102","author":"D. Hoppensteadt","year":"2008","unstructured":"D. Hoppensteadt, J. Fareed, A. L. Klein, et al., \u201cComparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation,\u201d Am. J. Cardiol. 102 (7), 842\u2013846 (2008).","journal-title":"Am. J. Cardiol."},{"key":"7378_CR20","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/jth.14821","volume":"18","author":"J. Thachil","year":"2020","unstructured":"J. Thachil, \u201cThe versatile heparin in COVID-19,\u201d J.\u00a0Thromb. Haemost. 18 (5), 1020\u20131022 (2020).","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"7378_CR21","first-page":"3950","volume":"130","author":"W. C. Song","year":"2020","unstructured":"W. C. Song and G. A. FitzGerald, \u201cCOVID-19, microangiopathy, hemostatic activation, and complement,\u201d J. Clin. Invest. 130, 3950\u20133953 (2020).","journal-title":"J. Clin. Invest."},{"key":"7378_CR22","doi-asserted-by":"crossref","unstructured":"M. Viecca, D. Radovanovic, G. B. Forleo, and P. Santus, \u201cEnhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability: A case control, proof of concept study,\u201d Pharmacol. Res. 158, 104950 (2020).","DOI":"10.1016\/j.phrs.2020.104950"},{"key":"7378_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/09537104.2019.1581920","volume":"31","author":"M. Ranucci","year":"2020","unstructured":"M. Ranucci, U. di Dedda, and E. Baryshnikova, \u201cPlatelet contribution to clot strength in thromboelastometry: Count, function, or both,\u201d Platelets 31 (1), 88\u201393 (2020).","journal-title":"Platelets"},{"key":"7378_CR24","doi-asserted-by":"crossref","unstructured":"A. Yu. Bulanov, A. I. Kostin, S. S. Petrikov, et al., \u201cClinical use of convalescent plasma in the treatment of a new coronavirus infection: Moscow experience,\u201d Anesteziol. Reanimatol., No. 6-2, 33\u201339 (2020).","DOI":"10.17116\/anaesthesiology202006233"},{"key":"7378_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.2020.10044","volume":"324","author":"L. Li","year":"2020","unstructured":"L. Li, W. Zhang, Y. Hu, et al., \u201cEffect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: A\u00a0randomized clinical trial,\u201d JAMA 324 (5), 460\u2013470 (2020).","journal-title":"JAMA"},{"key":"7378_CR26","unstructured":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance, March 13, 2020. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/331446\/WHO-2019-nCoV-clinical-2020.4-eng.pdf. Cited February 1, 2022."},{"key":"7378_CR27","unstructured":"Nutritional Support for Patients with COVID-19: Guidelines (Triada, Moscow, 2020) [in Russian]."},{"key":"7378_CR28","volume-title":"Parenteral and Enteral Nutrition: National Guidelines","year":"2014","unstructured":"Parenteral and Enteral Nutrition: National Guidelines, Ed. by M. Sh. Khubutiya, T. S. Popova, and A. I. Saltanov (GEOTAR-Media, Moscow, 2014) [in Russian]."},{"key":"7378_CR29","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","volume":"46","author":"W. Alhazzani","year":"2020","unstructured":"W. Alhazzani, M. H. M\u00f8ller, T. M. Arabi, et al., \u201cSurviving sepsis campaign: Guidelines of the management of critically ill. Adults with coronavirus disease 2019 (COVID-19),\u201d Intensive Care Med. 46 (5), 854\u2013887 (2020).","journal-title":"Intensive Care Med."},{"key":"7378_CR30","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.clnu.2020.03.022","volume":"39","author":"R. Barazzoni","year":"2020","unstructured":"R. Barazzoni, S. C. Bischoff, Z. Krznaric, et al., \u201cESPEN expert statements and practical guidance for nutritional management of individuals with Sars-Cov-2 infection,\u201d Clin. Nutr. 39 (6), 1631\u20131638 (2020). https:\/\/doi.org\/10.1016\/j.clnu.2020.03.022","journal-title":"Clin. Nutr."},{"key":"7378_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N. Chen","year":"2020","unstructured":"N. Chen, M. Zhou, X. Dong, et al., \u201cEpidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study,\u201d Lancet. 395 (10223), 507\u2013513 (2020).","journal-title":"Lancet."},{"key":"7378_CR32","unstructured":"R. G. Martindale, J. J. Patel, B. Taylor, et al., \u201cNutrition therapy in patient with COVID-19 disease requiring ICU Care: Updated May 26, 2020.\u201d https:\/\/www.nutritioncare.org\/uploadedFiles\/Documents\/Guidelines_and_Clinical_Resources\/COVID19\/Nutrition%20Therapy%20in%20the%20Patient%20with %20COVID-19%20Disease%20Requiring%20ICU%20Care_Updated%20May%2026.pdf. Cited February 1, 2022."},{"key":"7378_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clnu.2018.05.024","volume":"38","author":"D. Volkert","year":"2019","unstructured":"D. Volkert, A. M. Beck, T. Cederholm, et al., \u201cESPEN guideline on clinical nutrition and hydration in geriatrics,\u201d Clin. Nutr. 38 (1), 10\u201347 (2019).","journal-title":"Clin. Nutr."},{"key":"7378_CR34","doi-asserted-by":"crossref","unstructured":"J. Whittle, J. Molinger, D. MacLeod, et al., \u201cPersistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19,\u201d Crit. Care 24, Article no. 581 (2020).","DOI":"10.1186\/s13054-020-03286-7"},{"key":"7378_CR35","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","volume":"382","author":"P. K. Bhatraju","year":"2020","unstructured":"P. K. Bhatraju, B. J. Ghassemieh, M. Nichols, et al., \u201cCovid-19 in critically ill patients in the Seattle Region\u2014case series,\u201d New Engl. J. Med. 382 (21), 2012\u20132022 (2020).","journal-title":"New Engl. J. Med."},{"key":"7378_CR36","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1164\/rccm.202004-1163LE","volume":"201","author":"D. R. Ziehr","year":"2020","unstructured":"D. R. Ziehr, J. Alladina, C. R. Petri, et al., \u201cRespiratory pathophysiology of mechanically ventilated patients with COVID-19: A cohort study,\u201d Am. J. Respir. Crit. Care Med. 201 (12), 1560\u20131564 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"7378_CR37","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1513\/AnnalsATS.202004-376RL","volume":"17","author":"L. D. Bos","year":"2020","unstructured":"L. D. Bos, F. Paulus, A. P. J. Vlaar, et al., \u201cSubphenotyping ARDS in COVID-19 patients: Consequences for ventilator management,\u201d Ann. Am. Thorac. Soc. 17 (9), 1161\u20131163 (2020).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"7378_CR38","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","volume":"395","author":"M. J. Cummings","year":"2020","unstructured":"M. J. Cummings, M. R. Baldwin, D. Abrams, et al., \u201cEpidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A\u00a0prospective cohort study,\u201d Lancet 395 (10239), 1763\u20131770 (2020).","journal-title":"Lancet"},{"key":"7378_CR39","unstructured":"S. V. Zhuravel\u2019, D. A. Kosolapov, and M. V. Ketskalo, \u201cOrganization of an extracorporeal membrane oxygenation program in adult patients in a multifield hospital: Experience of Regensburg (Germany),\u201d Transplantologiya, No. 4, 28\u201332 (2014)."},{"key":"7378_CR40","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","volume":"378","author":"A. Combes","year":"2018","unstructured":"A. Combes, D. Hajage, G. Capellier, et al., \u201cExtracorporeal membrane oxygenation for severe acute respiratory distress-syndrome,\u201d New Engl. Med. 378 (21), 1965\u20131975 (2018).","journal-title":"New Engl. Med."},{"key":"7378_CR41","unstructured":"S. V. Zhuravel\u2019, A. K. Evseev, A. D. Kolokol\u2019tsev, et al., \u201cHistorical development and perspectives of extracorporeal membrane oxygenation in clinical practice,\u201d Vysokotekhnol. Med., No. 1, 51\u201358 (2020)."},{"key":"7378_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.15690\/vramn1412","volume":"75","author":"S. S. Petrikov","year":"2020","unstructured":"S. S. Petrikov, S. V. Zhuravel\u2019, L. V. Shogenova, et al., \u201cThermal helium\u2013oxygen mixture in the treatment algorithm for patients with COVID-19,\u201d Vestn. Ross. Akad. Med. Nauk 75 (5S), 353\u2013362 (2020).","journal-title":"Vestn. Ross. Akad. Med. Nauk"},{"key":"7378_CR43","doi-asserted-by":"crossref","unstructured":"S. D. Varfolomeev, A. A. Panin, V. I. Bykov, et al., \u201cThermovaccination\u2014thermoheliox as a stimulator of the immune response: Kinetics of the synthesis of antibodies and C-reactive protein in coronavirus infection,\u201d Chem. Biol. Interact. 334, Article no. 109339 (2021).","DOI":"10.1016\/j.cbi.2020.109339"},{"key":"7378_CR44","doi-asserted-by":"publisher","first-page":"533","DOI":"10.18093\/0869-0189-2020-30-5-533-543","volume":"30","author":"L. V. Shogenova","year":"2020","unstructured":"L. V. Shogenova, S. D. Varfolomeev, V. I. Bykov, et al., \u201cEffect of thermal helium\u2013oxygen mixture on viral load in COVID-19,\u201d Pul\u2019monologiya 30 (5), 533\u2013543 (2020).","journal-title":"Pul\u2019monologiya"},{"key":"7378_CR45","unstructured":"P. N. Savilov, \u201cOn the possibilities of hyperbaric oxygen therapy in the treatment of SARS-COV-2-infected patients,\u201d Znanstvena misel 42 (2), 55\u201360 (2020)."},{"key":"7378_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/2045-9912.282177","volume":"10","author":"P. G. Harch","year":"2020","unstructured":"P. G. Harch, \u201cHyperbaric oxygen treatment of novel coronavirus (COVID-19) respiratory failure,\u201d Med. Gas. Res. 10 (2), 61\u201362 (2020).","journal-title":"Med. Gas. Res."},{"key":"7378_CR47","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s12192-020-01121-0","volume":"25","author":"A. De Maio","year":"2020","unstructured":"A. De Maio and L. E. Hightower, \u201cCOVID-19, acute respiratory distress syndrome (ARDS) and hyperbaric oxygen therapy (HBOT): What is the link?,\u201d Cell Stress Chaperones 25 (5), 717\u2013720 (2020).","journal-title":"Cell Stress Chaperones"},{"key":"7378_CR48","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.apmr.2020.05.015","volume":"101","author":"S. Iannaccone","year":"2020","unstructured":"S. Iannaccone, P. Castellazzi, A. Tettamanti, et al., \u201cRole of rehabilitation department for adult individuals with COVID-19: The experience of the San Raffaele Hospital of Milan,\u201d Arch. Phys. Med. Rehabil. 101 (9), 1656\u20131661 (2020).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"7378_CR49","first-page":"652","volume":"56","author":"F. Negrini","year":"2020","unstructured":"F. Negrini, A. De Sire, E. Andrenelli, et al., \u201cThe International Multiprofessional Steering Committee of Cochrane Rehabilitation REH-COVER action. Rehabilitation and COVID-19: The Cochrane Rehabilitation 2020 rapid living systematic review. Update as of July 31, 2020,\u201d Eur. J. Phys. Rehabil. Med. 56 (5), 652\u2013657 (2020).","journal-title":"Eur. J. Phys. Rehabil. Med."}],"container-title":["Herald of the Russian Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1019331622040086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1019331622040086","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1019331622040086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:39:27Z","timestamp":1774247967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1019331622040086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["7378"],"URL":"https:\/\/doi.org\/10.1134\/s1019331622040086","relation":{},"ISSN":["1019-3316","1555-6492"],"issn-type":[{"value":"1019-3316","type":"print"},{"value":"1555-6492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"1 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}